Skip to main content
. 2024 Apr 16;39(1):53. doi: 10.1007/s00384-024-04627-6

Table 3.

Multi-treatment weighted logistic regression analysis for secondary endpoints

Endpoint/treatment NBP (No. = 3742)
OR (95% CI); p
oA (No. = 406)
OR (95% CI); p
MBP (No. = 1486)
OR (95% CI); p
MoABP (No. = 607)
OR (95% CI); p
sdiSSIs

3.3%

Reference

2.5%

0.67 (0.33–1.40); p = .285

4.9%

1.29 (0.81–2.07); p = .289

1.7%

0.29 (0.14–0.60); p = .001

Deep wound dehiscence

0.2%

Reference

0.7%

3.08 (0.84–11.2); p = .089

0.3%

0.75 (0.19–2.96); p = .678

0.2%

0.50 (0.06–4.13); p = .521

Abdominal collection/abscess

1.7%

Reference

0.7%

0.35 (0.08–1.51); p = .157

1.8%

1.53 (0.81–2.91); p = .190

1.0%

0.54 (0.15–1.88); p = .332

Major morbidity

5.3%

Reference

7.6%

2.07 (1.31–3.28); p = .002

6.7%

1.04 (0.72–1.52); p = .825

4.9%

0.71 (0.46–1.12); p = .140

Reoperation

4.6%

Reference

5.4%

1.48 (0.86–2.53); p = .158

6.2%

1.26 (0.86–1.85); p = .230

4.5%

0.76 (0.47–1.22); p = .250

Mortality

0.9%

Reference

0.5%

0.86 (0.21–3.48); p = .833

1.0%

1.38 (0.61–3.11); p = .439

0.3%

0.62 (0.11–3.38); p = .578

NBP no bowel preparation, oA oral antibiotics alone, MBP mechanical bowel preparation alone, MoABP mechanical bowel preparation and oral antibiotics, sdiSSIs superficial and/or deep incisional surgical site infections